These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. From p63 to p53 across p73. Strano S, Rossi M, Fontemaggi G, Munarriz E, Soddu S, Sacchi A, Blandino G. FEBS Lett; 2001 Feb 16; 490(3):163-70. PubMed ID: 11223031 [Abstract] [Full Text] [Related]
5. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. Nature; 2000 Oct 05; 407(6804):642-5. PubMed ID: 11034214 [Abstract] [Full Text] [Related]
6. Regulation and activation of p53 and its family members. Lohrum MA, Vousden KH. Cell Death Differ; 1999 Dec 05; 6(12):1162-8. PubMed ID: 10637431 [Abstract] [Full Text] [Related]
7. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1. Marabese M, Vikhanskaya F, Rainelli C, Sakai T, Broggini M. Nucleic Acids Res; 2003 Nov 15; 31(22):6624-32. PubMed ID: 14602923 [Abstract] [Full Text] [Related]
8. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Nicholson SA, Okby NT, Khan MA, Welsh JA, McMenamin MG, Travis WD, Jett JR, Tazelaar HD, Trastek V, Pairolero PC, Corn PG, Herman JG, Liotta LA, Caporaso NE, Harris CC. Cancer Res; 2001 Jul 15; 61(14):5636-43. PubMed ID: 11454718 [Abstract] [Full Text] [Related]
9. p14ARF links the tumour suppressors RB and p53. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH. Nature; 1998 Sep 10; 395(6698):124-5. PubMed ID: 9744267 [No Abstract] [Full Text] [Related]
10. Functional interplay between p53 and E2F through co-activator p300. Lee CW, Sørensen TS, Shikama N, La Thangue NB. Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736 [Abstract] [Full Text] [Related]
11. pRb inactivation in senescent cells leads to an E2F-dependent apoptosis requiring p73. Alexander K, Yang HS, Hinds PW. Mol Cancer Res; 2003 Aug 28; 1(10):716-28. PubMed ID: 12939397 [Abstract] [Full Text] [Related]
13. p73-mediated chemosensitivity: a preferential target of oncogenic mutant p53. Strano S, Blandino G. Cell Cycle; 2003 Aug 28; 2(4):348-9. PubMed ID: 12851488 [No Abstract] [Full Text] [Related]
14. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Blattner C, Sparks A, Lane D. Mol Cell Biol; 1999 May 28; 19(5):3704-13. PubMed ID: 10207094 [Abstract] [Full Text] [Related]
15. p53 family members: similar biochemistry, different biology. Barbieri CE, Pietenpol JA. Cancer Biol Ther; 2005 Apr 28; 4(4):419-20. PubMed ID: 15908776 [No Abstract] [Full Text] [Related]
16. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene. Chen D, Padiernos E, Ding F, Lossos IS, Lopez CD. Cell Death Differ; 2005 Apr 28; 12(4):358-68. PubMed ID: 15592436 [Abstract] [Full Text] [Related]
17. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Kim EJ, Park JS, Um SJ. Nucleic Acids Res; 2003 Sep 15; 31(18):5356-67. PubMed ID: 12954772 [Abstract] [Full Text] [Related]
18. Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes. La Sala D, Macaluso M, Trimarchi C, Giordano A, Cinti C. Oncogene; 2003 Jun 05; 22(23):3518-29. PubMed ID: 12789260 [Abstract] [Full Text] [Related]
19. Differential regulation of E2F transcription factors by p53 tumor suppressor protein. Vaishnav YN, Pant V. DNA Cell Biol; 1999 Dec 05; 18(12):911-22. PubMed ID: 10619603 [Abstract] [Full Text] [Related]
20. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC, DiMaio D. Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]